Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00743678 | Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis | completed | Phase 2 | 73 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01281761 | Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC) | completed | Phase 2 | 52 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01322152 |
| Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer |
| completed |
| Phase 2 |
| 52 |
| Fudan UniversityOTHER |
| 1 |
| Jun 11, 2013 |
| clinicaltrials |
| NCT00027729 | Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00028626 | Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00030862 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00040833 | Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00238394 | Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00033462 | Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer | completed | Phase 2 | 78 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00045526 | Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00075439 | Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00077441 | Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00084604 | Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00397787 | Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00220051 | A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer | completed | Phase 2 | 109 | Royal Marsden NHS Foundation TrustOTHER | 0 | May 31, 2013 | clinicaltrials |
| NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | completed | Phase 1 / Phase 2 | — | IntracelINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT01289288 | A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese(CRC) | completed | Phase 1 / Phase 2 | 480 | Georgetown UniversityOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00785122 | IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)(IMA910-101) | completed | Phase 1 / Phase 2 | 92 | Immatics Biotechnologies GmbHINDUSTRY | 9 | May 16, 2013 | clinicaltrials |
| NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00062257 | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | completed | Phase 2 | — | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00111774 | Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma | completed | Phase 2 | 150 | AmgenINDUSTRY | 0 | May 14, 2013 | clinicaltrials |
| NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | completed | Phase 2 | 52 | Seoul National University HospitalOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT00363051 | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | completed | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 11 | May 10, 2013 | clinicaltrials |
| NCT00290615 | Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 30 | Herbert HurwitzOTHER | 1 | May 7, 2013 | clinicaltrials |
| NCT00242502 | Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery | completed | Phase 2 | 62 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT00089960 | Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) | completed | Phase 2 | 138 | AmgenINDUSTRY | 0 | Apr 29, 2013 | clinicaltrials |
| NCT00660270 | Chemotherapy and Radiation Following Pancreatic Surgery | completed | Phase 2 | 53 | Washington University School of MedicineOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT00005076 | Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | 110 | University of Alabama at BirminghamOTHER | 0 | Apr 12, 2013 | clinicaltrials |
| NCT00033384 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01238055 | Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer | completed | Phase 2 | 116 | Samsung Medical CenterOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00258232 | Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00004003 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 30 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00017043 | BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01824004 | Postoperative Chemoradiotherapy With S-1 in Gastric Cancer | completed | Phase 2 | 46 | Chonnam National University HospitalOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00338039 | Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients | completed | Phase 2 | 69 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00655785 | Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2) | completed | Phase 1 / Phase 2 | 17 | Fukushima Medical UniversityOTHER | 1 | Mar 14, 2013 | clinicaltrials |
| NCT00540579 | CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas | completed | Phase 1 / Phase 2 | 23 | SCRI Development Innovations, LLCOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00837031 | Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas | completed | Phase 2 | 72 | SCRI Development Innovations, LLCOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00086931 | Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum | completed | Phase 1 / Phase 2 | 37 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00004066 | Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | completed | Phase 2 | 82 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | completed | Phase 2 | 24 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00003923 | Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas | completed | Phase 2 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00988741 | Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy | completed | Phase 2 | 107 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 5 | Feb 28, 2013 | clinicaltrials |
| NCT00071994 | Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) | completed | Phase 2 | 59 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00004870 | Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 1 / Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT01659619 | Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis | completed | Phase 2 | 114 | The Catholic University of KoreaOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | completed | Phase 2 | 136 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 14, 2013source: clinicaltrials